• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌的立体定向体部放疗:从物理学家视角看挑战与特点

SBRT for prostate cancer: Challenges and features from a physicist prospective.

作者信息

Mancosu Pietro, Clemente Stefania, Landoni Valeria, Ruggieri Ruggero, Alongi Filippo, Scorsetti Marta, Stasi Michele

机构信息

Humanitas Clinical and Research Hospital, Rozzano, Milano, Italy.

Azienda Ospedaliera Universitaria Federico II Napoli, Italy.

出版信息

Phys Med. 2016 Mar;32(3):479-84. doi: 10.1016/j.ejmp.2016.03.011. Epub 2016 Apr 6.

DOI:10.1016/j.ejmp.2016.03.011
PMID:27061869
Abstract

Emerging data are showing the safety and the efficacy of Stereotactic Body Radiation Therapy (SBRT) in prostate cancer management. In this context, the medical physicists are regularly involved to review the appropriateness of the adopted technology and to proactively study new solutions. From the physics point of view there are two major challenges in prostate SBRT: (1) mitigation of geometrical uncertainty and (2) generation of highly conformal dose distributions that maximally spare the OARs. Geometrical uncertainties have to be limited as much as possible in order to avoid the use of large PTV margins. Furthermore, advanced planning and delivery techniques are needed to generate maximally conformal dose distributions. In this non-systematic review the technology and the physics aspects of SBRT for prostate cancer were analyzed. In details, the aims were: (i) to describe the rationale of reducing the number of fractions (i.e. increasing the dose per fraction), (ii) to analyze the features to be accounted for performing an extreme hypo-fractionation scheme (>6-7Gy), and (iii) to describe technological solutions for treating in a safe way. The analysis of outcomes, toxicities, and other clinical aspects are not object of the present evaluation.

摘要

新出现的数据显示了立体定向体部放射治疗(SBRT)在前列腺癌治疗中的安全性和有效性。在此背景下,医学物理师经常参与审查所采用技术的适用性,并积极研究新的解决方案。从物理学角度来看,前列腺SBRT存在两个主要挑战:(1)减轻几何不确定性;(2)生成高度适形的剂量分布,以最大程度地减少对危及器官(OARs)的照射。必须尽可能限制几何不确定性,以避免使用较大的计划靶区(PTV)边界。此外,需要先进的计划和 delivery 技术来生成最大程度适形的剂量分布。在这篇非系统性综述中,分析了前列腺癌SBRT的技术和物理方面。具体而言,目的是:(i)描述减少分次次数(即增加每次分次剂量)的原理,(ii)分析实施超分割方案(>6 - 7Gy)时应考虑的特征,以及(iii)描述安全治疗的技术解决方案。对结果、毒性和其他临床方面的分析不是本评估的对象。 (注:原文中“delivery”未翻译完整,可能是“输送”等意思,需结合完整语境确定准确含义)

相似文献

1
SBRT for prostate cancer: Challenges and features from a physicist prospective.前列腺癌的立体定向体部放疗:从物理学家视角看挑战与特点
Phys Med. 2016 Mar;32(3):479-84. doi: 10.1016/j.ejmp.2016.03.011. Epub 2016 Apr 6.
2
Hypo-fractionated SBRT for localized prostate cancer: a German bi-center single treatment group feasibility trial.局部前列腺癌的低分割立体定向体部放疗:一项德国双中心单治疗组可行性试验
Radiat Oncol. 2017 Aug 18;12(1):138. doi: 10.1186/s13014-017-0872-2.
3
The march toward single-fraction stereotactic body radiotherapy for localized prostate cancer-Quo Vadimus?单剂量立体定向体部放疗治疗局限性前列腺癌的进展-我们将去往何方?
World J Urol. 2023 Dec;41(12):3485-3491. doi: 10.1007/s00345-023-04663-x. Epub 2023 Nov 3.
4
Tumor Control Probability Modeling and Systematic Review of the Literature of Stereotactic Body Radiation Therapy for Prostate Cancer.肿瘤控制概率建模及立体定向体部放射治疗前列腺癌文献的系统评价。
Int J Radiat Oncol Biol Phys. 2021 May 1;110(1):227-236. doi: 10.1016/j.ijrobp.2020.08.014. Epub 2020 Sep 6.
5
Dosimetry analyses comparing high-dose-rate brachytherapy, administered as monotherapy for localized prostate cancer, with stereotactic body radiation therapy simulated using CyberKnife.剂量学分析比较了高剂量率近距离放射治疗(作为局限性前列腺癌的单一疗法)与使用射波刀模拟的立体定向体部放射治疗。
J Radiat Res. 2014 Nov;55(6):1114-21. doi: 10.1093/jrr/rru048. Epub 2014 Jun 23.
6
Exploring All Avenues for Radiotherapy in Oligorecurrent Prostate Cancer Disease Limited to Lymph Nodes: A Systematic Review of the Role of Stereotactic Body Radiotherapy.探索局限于淋巴结寡复发前列腺癌疾病的放射治疗的所有途径:立体定向体部放射治疗作用的系统评价。
Eur Urol Focus. 2017 Dec;3(6):538-544. doi: 10.1016/j.euf.2017.07.006. Epub 2017 Aug 8.
7
Stereotactic body radiation therapy (SBRT) for genitourinary malignancies.用于泌尿生殖系统恶性肿瘤的立体定向体部放射治疗(SBRT)
Discov Med. 2010 Sep;10(52):255-62.
8
Frontiers in planning optimization for lung SBRT.肺部立体定向放疗计划优化的前沿进展
Phys Med. 2017 Dec;44:163-170. doi: 10.1016/j.ejmp.2017.05.064. Epub 2017 May 26.
9
PROstate Multicentre External beam radioTHErapy Using a Stereotactic boost: the PROMETHEUS study protocol.采用立体定向推量放疗的前列腺多中心外照射治疗:PROMETHEUS 研究方案。
BMC Cancer. 2018 May 24;18(1):588. doi: 10.1186/s12885-018-4511-6.
10
Stereotactic Body Radiation Therapy: A Radiosurgery Society Guide to the Treatment of Localized Prostate Cancer Illustrated by Challenging Cases.立体定向体部放射治疗:放射外科学会局部前列腺癌治疗指南(附挑战性病例图示)
Pract Radiat Oncol. 2024 Mar-Apr;14(2):e117-e131. doi: 10.1016/j.prro.2023.08.011. Epub 2023 Sep 3.

引用本文的文献

1
Exploration of an adaptive proton therapy strategy using CBCT with the concept of digital twins.利用CBCT并结合数字孪生概念探索一种自适应质子治疗策略。
Phys Med Biol. 2025 Jan 17;70(2):025010. doi: 10.1088/1361-6560/ada684.
2
Stereotactic body radiation therapy (SBRT) for prostate cancer: Improving treatment delivery efficiency and accuracy.前列腺癌的立体定向体部放射治疗(SBRT):提高治疗实施效率和准确性。
Tech Innov Patient Support Radiat Oncol. 2024 May 6;30:100253. doi: 10.1016/j.tipsro.2024.100253. eCollection 2024 Jun.
3
Adaptive radiation therapy strategies in the treatment of prostate cancer patients using hypofractionated VMAT.
使用少分次容积旋转调强放疗技术治疗前列腺癌患者的适应性放疗策略。
J Appl Clin Med Phys. 2021 Dec;22(12):7-26. doi: 10.1002/acm2.13415. Epub 2021 Nov 16.
4
Validation of a method for in vivo 3D dose reconstruction in SBRT using a new transmission detector.使用新型透射探测器对立体定向体部放疗中体内三维剂量重建方法的验证。
J Appl Clin Med Phys. 2017 Jul;18(4):69-75. doi: 10.1002/acm2.12103. Epub 2017 Jun 2.
5
Class solutions for SABR-VMAT for high-risk prostate cancer with and without elective nodal irradiation.针对有或无选择性淋巴结照射的高危前列腺癌的SABR-VMAT的类解决方案。
Radiat Oncol. 2016 Nov 24;11(1):155. doi: 10.1186/s13014-016-0730-7.